|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
|
|---|---|---|---|---|
| Assets | ||||
| CURRENT ASSETS: | ||||
| Cash and cash equivalents | ||||
| Short-term bank deposits | ||||
| Accounts receivable | ||||
| Governmental grant receivable | ||||
| Other receivables and prepaid expenses | ||||
| Inventories (Note 3) | ||||
| TOTAL CURRENT ASSETS | ||||
| NON-CURRENT ASSETS: | ||||
| Long-term bank deposits | ||||
| Right-of-use assets (Note 5) | ||||
| Property and equipment, net (Note 4) | ||||
| TOTAL NON-CURRENT ASSETS | ||||
| TOTAL ASSETS | ||||
| Liabilities and Shareholders’ Equity | ||||
| CURRENT LIABILITIES: | ||||
| Accounts payable | ||||
| Advance payments | ||||
| Convertible promissory note (Note 6) | ||||
| Accrued payroll and other employment related accruals | ||||
| Accrued expenses | ||||
| Lease liabilities | ||||
| TOTAL CURRENT LIABILITIES | ||||
| Lease liabilities | ||||
| TOTAL LIABILITIES | ||||
| SHAREHOLDERS’ EQUITY (Note 10): | ||||
| Ordinary shares no par value: Authorized 500,000,000 as of December 31, 2025 and 50,000,000 as of December 31, 2024; Issued and outstanding 2,882,802 shares as of December 31, 2025 and 235,821 shares as of December 31, 2024 | ||||
| Additional paid-in capital | ||||
| Accumulated losses | ||||
| TOTAL SHAREHOLDERS’ EQUITY | ||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||
Loading...
